Antiepileptic Drug Therapy for Status Epilepticus
Daeyoung Kim1, Jae Moon Kim2, Yong Won Cho3
1Department of Neurology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.
Journal of Clinical Neurology (Seoul, Korea)
|January 22, 2021
Summary
Status epilepticus (SE) treatment guidelines recommend benzodiazepines as first-line therapy. For established and refractory SE, recommendations for antiepileptic drug therapy are based on expert opinion and case series.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Status epilepticus (SE) is a critical neurological emergency with diverse causes and presentations.
- Effective treatment requires managing the underlying etiology and rapid seizure termination with antiepileptic drugs (AEDs).
Purpose of the Study:
- To provide practical, staged recommendations for AED therapy in SE.
- To synthesize existing guidelines and literature for clinical application.
Main Methods:
- Review of existing guidelines and scientific literature.
- Development of staged treatment recommendations for SE by the Drug Committee of the Korean Epilepsy Society.
Main Results:
- High-quality evidence supports benzodiazepines as the first-line treatment for SE.
- Limited high-quality evidence exists for second- and third-line treatments; recommendations rely on case series and expert consensus.
- Treatment decisions should balance patient-specific factors, benefits, and risks.
Conclusions:
- Staged AED therapy is crucial for managing SE.
- Concurrent treatment of underlying etiologies is essential alongside AEDs.
- Further research is needed to strengthen evidence for later-stage SE treatments.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: Sodium Channel Blockers
1.3K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.3K
Epilepsy and Seizures: Overview
896
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
896
Antiepileptic Drugs: Glutamate Antagonists
696
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
696
Antiepileptic Drugs: GABAergic Pathway Potentiators
955
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
955
Antiepileptic Drugs: Calcium Channel Blockers
875
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
875
Antiepileptic Drugs: Potassium Channel Activators
431
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
431


